AVITA Medical to Present at the TD Cowen 43rd Annual Health Care Conference
VALENCIA, Calif. and MELBOURNE, Australia, March 02, 2023 (GLOBE NEWSWIRE) — AVITA Medical, Inc. (NASDAQ:RCEL, ASX:AVH), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced today that Jim Corbett, Chief Executive Officer, will present at the TD Cowen 43rd Annual Health Care Conference in Boston on Tuesday, March 7, 2023, at 9:10 a.m. Eastern Time.
Related news for (RCEL)
- AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
- AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
- AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- AVITA Medical to Host Investor Webinar Briefing
- AVITA Medical Appoints New Non-Executive Member to the Board of Directors